DAV releases second round of historic potash resource estimates

Published 16-NOV-2017 12:12 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Davenport Resources (ASX:DAV) this morning followed up yesterday’s announcement —regarding the historic Resource at its 100%-owned Ebeleben mining license in Germany — with the release of the historic potash Resource at its 100%-owned Muhlhausen-Nohra license.

The resource for the company’s Muhlhausen-Nohra license includes 234 million tonnes at 14.4 per cent potassium oxide (K2O) — equivalent to 33.8 million tonnes of K2O.

The Muhlhausen sub-area adjoins the company’s existing Kullstedt exploration license. The below map shows its proximity to both Kullstedt and the Ebeleben:

Davenport resources licenses

According to DAV, the quality of the historic data will allow the company to rapidly advance its assessment of its South Harz Resources (both the Muhlhausen-Nohra license and the Ebeleben license) and achieve JORC compliance more expediently.

Further, the presence of mixed salts in the Muhlhausen area bodes well for the potential for parallel Muriate of Potash (MOP) and Sulphate of Potash (SOP) fertiliser production.

At the same time, it’s worth noting that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.

Regarding today’s announcement, Davenport Managing Director, Chris Bain said: “The historic resource for the southern part of Muhlhausen-Nohra follows the announcement of a historic resource of 356 million tonnes at 16.1 per cent K2O for the nearby Ebeleben Mining Licence.

“The presence of Hartsalz, a mixed salt that includes sulphates, in the Muhlhausen sub-area is notable as it potentially allows the production of both MOP and SOP fertilizer products.”

DAV recently acquired three perpetual mining licenses in the South Harz basin from German government agency Bodenverwertungs-und-verwaltungs GmbH (BVVG), which includes Muhlhausen-Nohrah and Ebeleben. Its holdings in the South Harz area now total 650 square kilometres.

The above resource for the Muhlhausen sub-area was estimated in 1980, with no known resource estimate having been done on the sub-area since. It should be noted that the estimate is a historical foreign estimate and is not reported in accordance with the JORC Code.

However, defining a JORC compliant Resource is top of the priority list for DAV, as it looks to prove up its newly acquired resources and re-establish the prominence of the South Harz as an important region for potash-production.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X